Strides Pharma Science Ltd.
Snapshot View

300.50 +1.65 ▲0.6%

09 February 2023, 03:19:55 PM
Volume: 129,613

Overview View Details >>

Sector Healthcare Compare with Sector peers
Industry Pharmaceuticals & Drugs Compare with Industry peers
Website http://www.strides.com
Market Cap 2,685.60 Cr.
Enterprise Value(EV) 5,471.83 Cr. 2022-09
Financial Indicators
Earnings per share (EPS) -18.15 Trailing Twelve Months Ending 2022-12
Price-Earning Ratio (PE) - Trailing Twelve Months Ending 2022-12
Industry PE 30.86 Trailing Twelve Months Ending 2022-12
Book Value / Share 264.10 Trailing Twelve Months Ending 2022-12
Price to Book Value 1.13 Calculated using Price: 297.40
Dividend Yield 0.00 Period Ending 2022-03
No. of Shares Subscribed 9.03 Cr. 90,302,704 Shares
FaceValue 10
Company Profile
The company's core competence is in the development and manufacture of wide range of niche and technically complex pharmaceutical products. The company is also among the world's largest soft gelatin capsule manufacturers.

Delivery View Details >>

Delivered Qty
Traded Qty

Performance View Details >>

1 Day
+0.55%
1 Week
-0.33%
1 Month
-14.86%
3 Month
-4.91%
6 Month
-11.88%
1 Year
-23.92%
2 Year
-64.64%
5 Year
-59.38%
10 Year
-68.56%
9 years 2014-03 2015-03 2016-03 2017-03 2018-03 2019-03 2020-03 2021-03 2022-03
Return on Equity (%) 3.36 0.09 5.25 16.53 27.00 14.74 5.83 12.91 -14.17
Return on Capital Employed (%) 7.76 10.92 7.54 10.75 16.07 8.65 6.13 11.17 -7.28
Return on Assets (%) 1.48 0.04 2.03 5.79 9.59 5.22 2.19 5.35 -5.35

Balance Sheet View Details >>

Particulars 10 years 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2022-09* Rs. Cr.
Shh. Funds 1,007 1,145 2,658 2,749 2,464 2,649 2,527 2,777 2,359 2,331
Non Curr. Liab. 306 286 2,760 2,049 2,067 2,343 814 1,264 966 978
Curr. Liab. 707 1,020 1,892 3,104 1,899 2,662 2,545 2,738 3,412 3,305
Minority Int. 76 19 50 134 155 153 67 37 24 -30
Equity & Liab. 2,096 2,469 7,360 8,035 6,585 7,807 5,953 6,817 6,761 6,585
Non Curr. Assets 788 1,040 3,845 4,243 4,101 4,758 3,581 4,000 3,399 3,331
Curr. Assets 1,309 1,429 3,515 3,792 2,484 3,049 2,372 2,817 3,362 3,254
Misc. Exp. not W/O
Total Assets 2,096 2,469 7,360 8,035 6,585 7,807 5,953 6,817 6,761 6,585

Profit Loss View Details >>

Particulars 10 years 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2022-12 Rs. Cr. TTM
Net Sales 1,341 1,196 2,862 3,826 3,344 3,108 2,752 3,316 3,070 3,568
Other Income 60 39 102 398 921 323 53 59 132 172
Total Income 1,401 1,234 2,965 4,224 4,265 3,431 2,805 3,375 3,202 3,740
Total Expenditure -1,118 -967 -2,482 -3,309 -3,109 -2,812 -2,236 -2,689 -3,090 -3,274
PBIDT 284 267 483 915 1,156 620 569 686 112 466
Interest -109 -47 -168 -183 -196 -79 -156 -150 -177 -230
Depreciation -56 -64 -131 -199 -194 -172 -174 -206 -233 -243
Taxation -41 -148 -42 -51 -21 -14 -11 -32 178 194
Exceptional Items -27 -7 -41 -36 -44 22 -78 43 -244 -87
PAT 51 1 100 446 701 376 151 342 -363 100
Minority Interest 1 14 -46 -20 -5 6 11 14 6
Share Associate -5 0 -17 -46 -107 -98 -111 -288
Other Related Items
Consolidated Net Profit 1,767 845 109 400 665 325 36 268 -460 -164
Adjusted EPS 9 0 12 45 74 36 4 30 -51 -18

Cash Flow View Details >>

Particulars 10 years 2012-12 Rs. Cr. 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr.
Cash Fr. Operatn. 134 -272 83 73 288 187 60 205 481 -258
Cash Fr. Inv. 807 4,077 52 -2,225 -687 583 -148 1,306 -521 -119
Cash Fr. Finan. -990 -3,319 -421 2,944 338 -1,016 194 -1,709 -16 421
Net Change -49 487 -286 792 -60 -246 106 -199 -55 45
Cash & Cash Eqvt 132 586 298 1,111 515 256 366 182 126 171

Shareholding Pattern View Details >>

9 Qtrs 2020-12 (%) 2021-03 (%) 2021-06 (%) 2021-09 (%) 2021-12 (%) 2022-03 (%) 2022-06 (%) 2022-09 (%) 2022-12 (%)
Promoter 29.69 29.67 29.62 29.60 29.60 30.60 30.37 31.07 30.89
Public 70.31 70.33 70.38 70.40 70.40 69.40 69.63 68.93 69.11
Depository Receipts 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Promoter Holding Pledge (%) 40.38 32.56 26.02 26.02 37.84 56.67 62.20 69.42 69.44

Announcements View Details >>

Tue, 07 Feb 2023
Shareholders meeting
Strides Pharma Science Limited has submitted the Exchange a copy Srutinizers report of Extraordinary General Meeting held on February 06, 2023. Further, the company has informed the Exchange regarding voting results.
Tue, 07 Feb 2023
Shareholders meeting
Strides Pharma Science Limited has submitted the Exchange a copy Srutinizers report of Extraordinary General Meeting held on February 06, 2023. Further, the company has informed the Exchange regarding voting results.
Thu, 02 Feb 2023
Analysts/Institutional Investor Meet/Con. Call Updates
Strides Pharma Science Limited has informed the Exchange about Transcript

Technical Scans View Details >>

Wed, 08 Feb 2023
Close Within 52 Week Low Zone Close Within 52 Week Low Zone
High Decrease in 1 Month High Decrease in 1 Month
High Decrease in 2 Years High Decrease in 2 Years
Tue, 07 Feb 2023
Closing Above Previous High Closing Above Previous High
Close Within 52 Week Low Zone Close Within 52 Week Low Zone

Related Stocks View Details >>

Stock Name Market Cap(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. 243,148.61 1,006.25 -0.7%
Cipla Ltd. 83,886.47 1,020.65 -1.8%
Dr. Reddy's Laboratories Ltd. 74,707.50 4,487.30 0.0%
Divi's Laboratories Ltd. 74,340.49 2,827.00 +1.0%
Apollo Hospitals Enterprise Ltd. 63,077.61 4,382.60 -0.2%
Torrent Pharmaceuticals Ltd. 52,675.65 1,539.10 -1.1%
Zydus Lifesciences Ltd. 47,993.66 474.50 +0.1%
Stock Name Statement TTM Ending Price Earning Ratio(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-12 57.66 1,006.25 -0.7%
Cipla Ltd. Consolidated 2022-12 31.80 1,020.65 -1.8%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-12 20.50 4,487.30 0.0%
Divi's Laboratories Ltd. Consolidated 2022-12 31.01 2,827.00 +1.0%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-09 75.13 4,382.60 -0.2%
Torrent Pharmaceuticals Ltd. Consolidated 2022-12 63.19 1,539.10 -1.1%
Zydus Lifesciences Ltd. Consolidated 2022-12 23.29 474.50 +0.1%
Stock Name Statement TTM Ending Price To Book Value(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-12 4.39 1,006.25 -0.7%
Cipla Ltd. Consolidated 2022-12 3.70 1,020.65 -1.8%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-12 3.39 4,487.30 0.0%
Divi's Laboratories Ltd. Consolidated 2022-12 5.98 2,827.00 +1.0%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-09 10.54 4,382.60 -0.2%
Torrent Pharmaceuticals Ltd. Consolidated 2022-12 8.24 1,539.10 -1.1%
Zydus Lifesciences Ltd. Consolidated 2022-12 2.78 474.50 +0.1%
Stock Name Statement Year Ending Debt Equity Ratio LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 0.03 1,006.25 -0.7%
Cipla Ltd. Consolidated 2022-03 0.04 1,020.65 -1.8%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 0.18 4,487.30 0.0%
Divi's Laboratories Ltd. Consolidated 2022-03 0.00 2,827.00 +1.0%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 0.47 4,382.60 -0.2%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 0.68 1,539.10 -1.1%
Zydus Lifesciences Ltd. Consolidated 2022-03 0.25 474.50 +0.1%
Stock Name Statement Year Ending Return On Equity(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 7.21 1,006.25 -0.7%
Cipla Ltd. Consolidated 2022-03 13.10 1,020.65 -1.8%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 11.55 4,487.30 0.0%
Divi's Laboratories Ltd. Consolidated 2022-03 28.16 2,827.00 +1.0%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 21.60 4,382.60 -0.2%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 13.18 1,539.10 -1.1%
Zydus Lifesciences Ltd. Consolidated 2022-03 15.51 474.50 +0.1%
Stock Name Statement Year Ending Return On Capital Employed(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 7.21 1,006.25 -0.7%
Cipla Ltd. Consolidated 2022-03 13.10 1,020.65 -1.8%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 11.55 4,487.30 0.0%
Divi's Laboratories Ltd. Consolidated 2022-03 28.16 2,827.00 +1.0%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 21.60 4,382.60 -0.2%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 13.18 1,539.10 -1.1%
Zydus Lifesciences Ltd. Consolidated 2022-03 15.51 474.50 +0.1%
Stock Name Statement Year Ending Net Sales(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 38,654.49 1,006.25 -0.7%
Cipla Ltd. Consolidated 2022-03 21,763.34 1,020.65 -1.8%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 21,545.20 4,487.30 0.0%
Divi's Laboratories Ltd. Consolidated 2022-03 8,959.83 2,827.00 +1.0%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 14,662.60 4,382.60 -0.2%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 8,508.04 1,539.10 -1.1%
Zydus Lifesciences Ltd. Consolidated 2022-03 15,265.20 474.50 +0.1%
Stock Name Statement Year Ending Profit After Tax(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 3,405.82 1,006.25 -0.7%
Cipla Ltd. Consolidated 2022-03 2,559.47 1,020.65 -1.8%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 2,112.20 4,487.30 0.0%
Divi's Laboratories Ltd. Consolidated 2022-03 2,960.45 2,827.00 +1.0%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 1,101.10 4,382.60 -0.2%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 777.18 1,539.10 -1.1%
Zydus Lifesciences Ltd. Consolidated 2022-03 2,326.40 474.50 +0.1%

FAQ's On Strides Pharma Science Ltd.

What is Strides Pharma Scien share price?

Can I buy Strides Pharma Scien shares now?

What is the Market Cap of Strides Pharma Scien?

What are the key metrics to analyse Strides Pharma Scien?

What is the 52 Week High and Low of Strides Pharma Scien?

What is the trend of Strides Pharma Scien share price?